Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)
CNY 68.99
(-0.95%)
CNY 68.99
(-0.95%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.9 Billion CNY | -20.13% |
| 2022 | 4.89 Billion CNY | 39.77% |
| 2021 | 3.49 Billion CNY | 53.64% |
| 2020 | 2.27 Billion CNY | 97.31% |
| 2019 | 1.15 Billion CNY | 191.83% |
| 2018 | 395.56 Million CNY | 27.34% |
| 2017 | 310.64 Million CNY | 8.62% |
| 2016 | 285.98 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.03 Billion CNY | 3.25% |
| 2024 Q3 | 3.85 Billion CNY | -3.68% |
| 2024 Q2 | 4 Billion CNY | -0.72% |
| 2023 Q4 | 3.9 Billion CNY | -8.86% |
| 2023 FY | 3.9 Billion CNY | -20.13% |
| 2023 Q3 | 4.28 Billion CNY | -1.46% |
| 2023 Q2 | 4.34 Billion CNY | -7.76% |
| 2023 Q1 | 4.71 Billion CNY | -3.59% |
| 2022 Q4 | 4.89 Billion CNY | 5.16% |
| 2022 Q3 | 4.65 Billion CNY | 3.88% |
| 2022 Q2 | 4.47 Billion CNY | 1.64% |
| 2022 Q1 | 4.4 Billion CNY | 25.88% |
| 2022 FY | 4.89 Billion CNY | 39.77% |
| 2021 FY | 3.49 Billion CNY | 53.64% |
| 2021 Q2 | 2.39 Billion CNY | -9.73% |
| 2021 Q1 | 2.65 Billion CNY | 16.36% |
| 2021 Q3 | 3.06 Billion CNY | 28.07% |
| 2021 Q4 | 3.49 Billion CNY | 14.21% |
| 2020 Q3 | 1.88 Billion CNY | 20.56% |
| 2020 Q1 | 1.31 Billion CNY | 14.28% |
| 2020 FY | 2.27 Billion CNY | 97.31% |
| 2020 Q4 | 2.27 Billion CNY | 21.11% |
| 2020 Q2 | 1.55 Billion CNY | 18.25% |
| 2019 Q3 | 444.83 Million CNY | 6.54% |
| 2019 Q2 | 417.53 Million CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q4 | 1.15 Billion CNY | 159.5% |
| 2019 FY | 1.15 Billion CNY | 191.83% |
| 2018 Q4 | 395.56 Million CNY | 0.0% |
| 2018 FY | 395.56 Million CNY | 27.34% |
| 2017 FY | 310.64 Million CNY | 8.62% |
| 2016 FY | 285.98 Million CNY | 0.0% |